Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CTNMCTNM
Showing 8 of 9 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in CONTINEUM THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 693,188 shares of CTNM (CONTINEUM THERAPEUTICS INC), worth $11.4M as of 2026-Q2. The position was increased (+145.8% shares). CTNM represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$11.4M

Current Shares

693,188

Total Value Change

+$8.9M

Total Shares Change

+564,512

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
693,188
+145.8%
$11.4M0.0%$16.39
45
2026-Q1
Increased
282,038
+31.9%
$3.7M0.0%$14.10
34
2025-Q4
Increased
213,869
+1.3%
$2.4M0.0%$11.40
26
2025-Q3
Increased
211,050
+196.0%
$2.5M0.0%$11.82
42
2025-Q2
Decreased
71,303
-63.1%
$283,1750.0%$4.11
0
2025-Q1
Increased
193,051
+2.5%
$1.3M0.0%$7.07
26
2024-Q4
Increased
188,408
+46.4%
$2.8M0.0%$14.47
36
2024-Q3
Decreased
128,676
-17.7%
$2.5M0.0%$18.84
0

Other major holders of CTNM: Janus Henderson Group Ltd., BlackRock, Inc., FRANKLIN RESOURCES INC, BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used